Income tax expense · 2011–2025
Alnylam Pharmaceuticals income tax expense
$9.4M+$109M · FY2025
Alnylam Pharmaceuticals (ALNY) reported $9.4M in income tax expense for fiscal 2025, +$109M from the year before.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $9.4M | +$109M | Open → |
| FY20242024-12-31 | −$99.2M | −$106M | Open → |
| FY20232023-12-31 | $6.7M | +61.5% | Open → |
| FY20222022-12-31 | $4.2M | +512.2% | Open → |
| FY20212021-12-31 | $680,000 | −74.6% | Open → |
| FY20202020-12-31 | $2.7M | +210.7% | Open → |
| FY20192019-12-31 | $863,000 | +4.9% | Open → |
| FY20182018-12-31 | $823,000 | +$823,000 | Open → |
| FY20172017-12-31 | $0 | $0 | Open → |
| FY20162016-12-31 | $0 | $0 | Open → |
| FY20152015-12-31 | $0 | +$40.2M | Open → |
| FY20142014-12-31 | −$40.2M | −$37.5M | Open → |
| FY20132013-12-31 | −$2.7M | +$7.9M | Open → |
| FY20122012-12-31 | −$10.6M | −$10.6M | Open → |
| FY20112011-12-31 | $0 | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Alnylam Pharmaceuticals income tax expense |url=https://companiesranked.com/en/company/alnylam-pharmaceuticals/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Alnylam Pharmaceuticals income tax expense. CompaniesRanked. https://companiesranked.com/en/company/alnylam-pharmaceuticals/income-tax-expenseBibTeX
@misc{companiesranked-en-company-alnylam-pharmaceuticals-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Alnylam Pharmaceuticals income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/alnylam-pharmaceuticals/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-007497 · February 12, 2026
{{cite web |title=Alnylam Pharmaceuticals income tax expense — 10-K (0001628280-26-007497) |url=https://www.sec.gov/Archives/edgar/data/1178670/000162828026007497/alny-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-12}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.